DM
Therapeutic Areas
ImmunoGenesis Pipeline
| Drug | Indication | Phase |
|---|---|---|
| IMGS-001 | Immune-excluded (cold) tumors | Pre-clinical / Phase 1 implied |
| IMGS-101 (evofosfamide) | Hypoxic, immune-excluded tumors | Pre-clinical / Phase 1 implied |
| IMGS-203 | Not specified (Oncology) | Pre-clinical |